Found 7 matching trials
Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension PHASE3 This study examines the long term safety and efficacy of the Fixed Dose com...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pharmacogenomic Study of Candesartan in Heart Failure PHASE4 The purpose of this study is to evaluate the impact of genetic variations o...
Show More Location
Montreal Heart Institute
Learn More & Join Trial
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension PHASE4 The purpose of this study is to see if Candesartan, once daily (QD), added ...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of Diabetes on Left Ventricular Remodeling PHASE2 The investigators hypothesize that in patients with diabetes and acute myoc...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients. PHASE3 The purpose of this study is to determine the effects of candesartan, once ...
Show More Location
Multiple Locations
Learn More & Join Trial
Improved Treatment and Monitoring of Alzheimer's Disease PHASE2 In the world's high-income countries, Alzheimer's disease and other dementi...
Show More Location
Multiple Locations
Learn More & Join Trial
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) PHASE4 This is a multicenter, prospective, open-label, randomized, investigator-in...
Show More Location
Seoul National University Hospital
Learn More & Join Trial